Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

Google has announced that using its newly incorporated Lyria 3 model, Gemini users will be able to generate 30-second music tracks based on a prompt, or remix an existing track to their liking. The ...

Seedance 2.0 can take camera movement, visual effects, and motion into account. Seedance 2.0 can take camera movement, visual effects, and motion into account. is a news writer who covers the ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...

Abstract: An interview is a stage to dig up information for participants who want to know the profile and matching to the interviewer's needs. The development of interviews using bots has undergone ...

PythoC lets you use Python as a C code generator, but with more features and flexibility than Cython provides. Here’s a first look at the new C code generator for Python. Python and C share more than ...

The Paraphrase Project addresses a critical and emerging risk: as generative AI and synthetic biology advance, there is a growing possibility that open-source AI tools could be misused to design ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min There's been a lot of talk about ...